Financhill
Back

Citius Pharmaceuticals Stock Predictions

Citius Pharmaceuticals Stock Forecast

  • Is Citius Pharmaceuticals Stock Undervalued?
    The current Citius Pharmaceuticals [CTXR] share price is $0.55. The Score for CTXR is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • CTXR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Citius Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Citius Pharmaceuticals Stock Rating

Data Unavailable

Citius Pharmaceuticals Stock Price History

Is CTXR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
citiuspharma.com

52-Week Data

52-Week High:
1.07
52-Week Low:
0.48

Prediction Charts

Market Cap:
99.06M
Price in USD:
0.55
Volume:
1.8M
Beta:
1.16

Technical Analysis

SMA50:
0.71
SMA100:
0.68
SMA200:
0.72
52-Wk Change:
-23.4%

Stock Predictions

  • Is Citius Pharmaceuticals stock public?
    Yes, Citius Pharmaceuticals is a publicly traded company.
  • What is the Citius Pharmaceuticals stock quote today?
    The Citius Pharmaceuticals stock price is 0.55 USD today.
  • How to buy Citius Pharmaceuticals stock online?
    You can buy Citius Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-30 0.57 0.57 0.59 0.56
Sep-3 0.58 0.55 0.59 0.53
Sep-4 0.57 0.55 0.59 0.54
Sep-5 0.57 0.54 0.58 0.54
Sep-6 0.54 0.53 0.57 0.52
Sep-9 0.53 0.53 0.56 0.52
Sep-10 0.55 0.54 0.55 0.52
Sep-11 0.54 0.53 0.54 0.48
Sep-12 0.53 0.52 0.54 0.51
Sep-13 0.52 0.52 0.53 0.51
Sep-16 0.51 0.50 0.53 0.49
Sep-17 0.51 0.50 0.53 0.50
Sep-18 0.50 0.52 0.52 0.50
Sep-19 0.54 0.55 0.58 0.52

Citius Pharmaceuticals Earnings

Data Unavailable

Citius Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.10 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.

* Citius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.